-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Quest Diagnostics, Raises Price Target to $250

Benzinga·07/28/2026 13:48:13
語音播報
JP Morgan analyst Lisa Gill maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $220 to $250.